EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab

J Invest Dermatol. 2022 Dec;142(12):3335-3337.e1. doi: 10.1016/j.jid.2022.06.008. Epub 2022 Jul 16.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Dermatitis, Atopic* / diagnosis
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • tralokinumab
  • Antibodies, Monoclonal